Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation.
about
Intracellular activation of interferon regulatory factor-1 by nanobodies to the multifunctional (Mf1) domainSpecific in vivo knockdown of protein function by intrabodiesX-ray crystal structure of bone marrow kinase in the x chromosome: a Tec family kinaseIn-cell intrabody selection from a diverse human library identifies C12orf4 protein as a new player in rodent mast cell degranulationProtocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture.Synthetic antibodies as tools to probe RNA-binding protein function.A V(L) single-domain antibody library shows a high-propensity to yield non-aggregating binders.Single domain antibodies for the knockdown of cytosolic and nuclear proteins.Intrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cells.Therapeutic antibodies: successes, limitations and hopes for the future.Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk/BMXResearch and development of next generation of antibody-based therapeuticsEngineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteinsBMX and its role in inflammation, cardiovascular disease, and cancer.Single-domain antibodies for biomedical applications.Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifsIntracellular antibodies and cancer: new technologies offer therapeutic opportunities.
P2860
Q24634375-50A0A6DC-C74B-4D7B-8402-7F38E0D28E7CQ26801077-151314DB-60EC-4C4F-99CB-E407500C1529Q27672770-76841A14-54A3-44D2-A087-E945DEBEB383Q28573830-BA80B88A-812B-4DF9-A0B3-8BE4F66A2E94Q33522558-13FAB9AC-1027-4745-BC53-70D8C614C9BAQ34223399-0FC7EBFC-A29A-409A-8F11-C8E746A26C02Q34227317-B72342F6-C692-438A-8B04-C43A95C95419Q36300378-FCC69B60-FE69-421D-AA91-E48418654B74Q36370665-8E971449-2756-4EE5-9134-0358121A0293Q37491236-509B73CF-F784-48C3-A8D0-73B5648F0BA3Q37571975-6A8FDE25-4DF5-455F-9D74-0C6145A70766Q37593692-2D53F5FB-A6D4-4E84-B5E3-708939653862Q37742282-71EE498E-817F-4C7C-A256-7525CB1201AEQ37778732-68BA24F3-EC10-4F1F-B5DB-1B3C73DE51AFQ37961564-DF14FABD-8526-471D-82F3-F1A5503A929BQ37997079-46B4437E-7B89-445E-8B41-EC9681E17BC8Q38628712-1129838A-4DFD-420D-B062-6C30D7D34CFBQ39560754-9468F89C-DFA6-404A-919B-E31E63163B3AQ39674045-DB93757B-9C5E-49D1-B6FB-70D0D3A18EAAQ39864280-0891DE53-1FDB-4243-8544-A17A2D9C0A10
P2860
Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Human single-domain neutralizi ...... mpair cellular transformation.
@ast
Human single-domain neutralizi ...... mpair cellular transformation.
@en
type
label
Human single-domain neutralizi ...... mpair cellular transformation.
@ast
Human single-domain neutralizi ...... mpair cellular transformation.
@en
prefLabel
Human single-domain neutralizi ...... mpair cellular transformation.
@ast
Human single-domain neutralizi ...... mpair cellular transformation.
@en
P2093
P1476
Human single-domain neutralizi ...... mpair cellular transformation.
@en
P2093
Jacqueline Doody
Laura A Brennan
Michelle Iacolina
Yaron R Hadari
Zhenping Zhu
P304
P356
10.1158/1535-7163.MCT-05-0174
P577
2005-11-01T00:00:00Z